Tenecteplase (TNK-tPA)
Tenecteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction, PE
Tenecteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction, PE
Aubrey Otis Hampton (1900 - 1955) was an American Radiologist. Eponymously affiliated with Hampton hump and Hampton line
Malignant Hyperthermia = pharmacogenetic disease of skeletal muscle induced by exposure to certain anaesthetic agents; incidence 1:5,000 -> 1:65,000 anaesthetics (suspected); mutation in the gene coding for the ryanodine receptor
Anticholinergic Syndrome
Much of what we do in toxicology is because we think it works, not because we know it works. Clinical toxicology has traditionally been based on animal studies, case reports and case series based on clinical observation rather than clinical trials
Iron overdose can have local gastrointestinal effects as well as characteristic systemic toxicity (metabolic acidosis, liver failure, shock and multi-organ failure). Risk assessment is based on the amount of elemental iron ingested
Severe toxicity from plants is rare in humans; risk assessment is often difficult - plant identification may be difficult; - toxin quantification may be impossible
Chilaiditi syndrome: symptomatic hepatodiaphragmatic interposition associated with abdominal pain, nocturnal vomiting, anorexia, and abdominal distension.
Base of Skull Fracture: fracture involving the floor of the cranial vault
Pacing Modes – Advantages and Disadvantages
electromagnetic interference can affect the function of implanted electronic devices such as pacemakers and ICDs
Temporary Pacemaker Troubleshooting. Problems with pacing: output failure, failure to capture. Problems with sensing: oversensing, undersensing and Pacemaker syndromes